Navigation Links
Overlooked ugly cholesterol causes heart disease
Date:1/21/2013

THE GOOD, THE BAD AND THE UGLY The risk of ischaemic heart disease a disease affecting some 150,000 Danes is three times higher in persons with high levels of the so-called 'ugly' cholesterol. This is the finding of a new study of 73,000 Danes, which is shedding light on a long debate on this topic. The results have just been published in the Journal of the American College of Cardiology.

Most Danes are aware that high cholesterol is life-threatening. But very few know which type of cholesterol is the most frequent killer. Cholesterol is divided into 'the good' HDL cholesterol, 'the bad' LDL cholesterol and 'the ugly' cholesterol. It is the so-called 'ugly cholesterol' also called 'remnant-like particle cholesterol' that is the really bad guy.

"LDL cholesterol or 'the bad' cholesterol' is of course bad, but our new study reveals that the ugly cholesterol is the direct cause of arteriosclerosis (hardening of the arteries) resulting in ischaemic heart disease and early death. By examining 73,000 persons, we found that an increase in the ugly cholesterol triples the risk of ischaemic heart disease, which is caused by lack of oxygen to the heart muscle due to narrowing or blocking of the coronary arteries," says Professor Brge Nordestgaard, chief physician at Herlev Hospital and Clinical Professor at the Faculty of Health Sciences at the University of Copenhagen.

"I hope that this new knowledge will lead to better preventive treatment, as more than one in five Danes suffers from high ugly cholesterol. We also hope that the pharmaceutical industry will develop new drugs targeted specifically at raised ugly cholesterol levels," he emphasises.

Widespread disease worldwide

In Denmark alone, 20,000 persons are diagnosed with ischaemic heart disease every year, and some 150,000 Danes are currently affected by the disease. According to World Health Organization estimates, 17 million people fall victim to cardiovascular disease the most frequent cause of death in the world.

"High ugly cholesterol is the result of high blood levels of normal fat (triglycerides). The most important cause of high ugly cholesterol is overweight and obesity. Persons with high ugly cholesterol should therefore be advised to lose weight, but drugs such as statins and fibrates may also lower levels of ugly cholesterol in the blood," says Brge Nordestgaard.

Samples from 73,000 Danes with genetic defect

Anette Varbo, physician and PhD student at Herlev Hospital, has been part of the research team behind the new findings. She says that the findings shed light on a long-standing debate among researchers on the so-called triglyceride, arteriosclerosis and cholesterol.

"To be able to examine the correlation between ugly cholesterol and heart disease, we have used blood samples from persons having a genetic defect which means that they suffer from high ugly cholesterol their entire life. The research findings do therefore not depend on their lifestyle patterns in general. Unhealthy lifestyle factors such as smoking, fatty foods and overweight all increase the risk of heart disease, and the blood samples from persons having this genetic defect thus give the most accurate results," says Anette Varbo.


'/>"/>

Contact: Brge Nordestgaard
Boerge.Nordestgaard@regionh.dk
45-30-28-72-63
University of Copenhagen
Source:Eurekalert

Related medicine news :

1. Cancer-Related Fatigue Often Overlooked, Study Finds
2. Eczema Non-Profit Seeks To Shine New Light On Overlooked Condition
3. Patient mental health overlooked by physician when a family member is present
4. Smoking, high blood pressure and cholesterol can be fatal for hemorrhage survivors
5. Cholesterol medicine affects energy production in muscles
6. VABC Responds to Study on Use of Cholesterol Lowering Drug Statins on Cancer Patients
7. Statins Plus Exercise Best at Lowering Cholesterol, Study Finds
8. Letter from doctor boosts cholesterol medication use
9. No Need to Fast Before Cholesterol Blood Test: Study
10. New drug significantly lowers bad cholesterol
11. Could Cholesterol Treatment Fight Repeat Heart Attack?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... , ... July 24, 2017 , ... ... office at 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. The office opened ... M.D. and physician assistants Lori Friedman and Fruma Leah Wiederman. , Advanced ...
(Date:7/24/2017)... ... 24, 2017 , ... “Nana Nana Boo Boo”: a delightful tale of a ... “Nana Nana Boo Boo” is the creation of published author Michael Rush, a Deputy ... Faith Publishing, Michael Rush’s new book presents the importance of manners in a way ...
(Date:7/24/2017)... ... ... “Journey to the Light: The Quest for Happiness and Love. . . through Faith”: ... “Journey to the Light: The Quest for Happiness and Love. . . through ... manuals, and articles, who has recently decided to expand her literary horizons and write ...
(Date:7/23/2017)... Alexandria, Virginia (PRWEB) , ... July 24, 2017 ... ... during the American Association of Physicists in Medicine (AAPM) 59th Annual Meeting & ... , Members of the medical physics profession, hospital administrators and journalists can visit ...
(Date:7/23/2017)... ... July 23, 2017 , ... A 20-year-long study by a national ... the Minneapolis Veterans Administration Health Care System overwhelmingly supports growing evidence that prostate cancer ... benefits. , In the cases involved with this study, surgery did not prolong ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 10, 2017  The tenth annual BioPharm America™ ... at the Sheraton Boston Hotel, September 26–27. ... to global decision makers and innovative biotech startup companies. ... leaders during two impactful days. BioPharm America is now ... additional networking opportunities with 4,500+ life science industry influencers ...
(Date:7/5/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on the development of ... approval from the Israel Securities Authority to dual-list its common ... stock will commence trading on the TASE on July 12, ... capitalization of the Company, it is expected that Oramed will ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology: